ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

NTP Release Third Report On Carcinogens

January 13, 1984

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011